Founded in 2022, Iom Bioworks operates in Health Tech industry. Initially focusing on creating a platform for early detection of diseases through urine analysis, the company has further refined its te...
Funding stage:
Seed
Last funding:
11/06/2025
Total funding:
$463.75K+
Revenue:
Investors
Employee count:
19
Last 90d
19
Last 90d
Web traffic:
130
130
Last 30d
Last 30d
Iom Bioworks: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders40
Latest Filing Date10 May 2026- Funding Events13
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Iom Bioworks
As of 11 May 2026, Iom Bioworks's equity is held by 38 shareholders, with the top three being Bipin Pradeep Kumar, Hiroaki Kitano, and Samik Ghosh.
Bipin Pradeep Kumar holds the largest stake in Iom Bioworks at 24.7% as of 11 May 2026.
As of 11 May 2026, founders collectively hold 74.1% equity in Iom Bioworks.
As of 11 May 2026, investors collectively hold 11.8% equity in Iom Bioworks.
Iom Bioworks's ESOP pool stands at 8.9% of total equity as of 11 May 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links